CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 88 filers reported holding CUREVAC N V in Q2 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $33,500,000 | 18.01% |
| Renaissance Capital LLC | 16,668 | $327,000 | 0.14% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 52,996 | $1,039,000 | 0.09% |
| Neo Ivy Capital Management | 4,614 | $90,000 | 0.08% |
| TWINBEECH CAPITAL LP | 82,547 | $1,619,000 | 0.07% |
| Baillie Gifford | 3,911,347 | $76,702,000 | 0.05% |
| CAPITAL FUND MANAGEMENT S.A. | 233,371 | $4,576,405,000 | 0.04% |
| Virtus ETF Advisers LLC | 4,028 | $79,000 | 0.04% |
| Bayesian Capital Management, LP | 11,736 | $230,000 | 0.03% |
| Dynamic Technology Lab Private Ltd | 14,181 | $278,000 | 0.03% |